Dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl-tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors

Molecular Pharmacology

Volumn 49, Issue 5, 1996, Pages 761-765

  Yu, Xian Jie ^a   Waeber, Christian ^a   Castanon, Nathalie ^b   Scearce, Kimberly ^b   Hen, René ^b   Macor, John E ^d,e   Chaveau, Jacques ^c   Moskowitz, Michael A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Columbia University ^*  (United States)

^c Immunotech   (France)

^d PFIZER INC   (United States)

^e Astra Arcus USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDIN 5 ONE; 5 CARBAMOYLTRYPTAMINE; 5 METHYLAMINOSULFONYLMETHYL 3 (1 METHYL 2 PYRROLIDINYLMETHYL) 1H INDOLE; ALBUMIN I 125; BOVINE SERUM ALBUMIN; CAPSAICIN; DIHYDROERGOTAMINE; PLASMA PROTEIN; RECEPTOR SUBTYPE; SEROTONIN 1 AGONIST; SEROTONIN 1B RECEPTOR; SEROTONIN 5 O CARBOXYMETHYLGLYCYLTYROSINAMIDE; SUBSTANCE P; SUMATRIPTAN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DURA MATER; ELECTROSTIMULATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRIGEMINUS GANGLION;

ANIMALS; CAPILLARY PERMEABILITY; DIHYDROERGOTAMINE; DIPEPTIDES; MICE; MICE, KNOCKOUT; PYRIDINES; PYRROLES; PYRROLIDINES; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SUMATRIPTAN; TRIGEMINAL GANGLION;

EID: 0030005798     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Markowitz, S., K. Saito, and M. A. Moskowitz. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J. Neurosci. 7:4129-4136 (1987).
2. 1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia 11:165-168 (1991).
3. Buzzi, M. G., M. A. Moskowitz, S. J. Peroutka, and B. Byun. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma protein extravasation in rat dura mater. Br. J. Pharmacol. 103:1421-1428 (1991).
4. Lee, W. S., and M. A. Moskowitz. Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638 exhibit enhanced potency against neurogenic inflammation in dura mater. Brain Res. 626:303-305 (1993).
5. 1D receptor genes. Trends Pharmacol. Sci. 13:152-159 (1992).
6. 1Dβ receptor subtypes. Eur. J. Pharmacol. 291:9-15 (1995).
7. 1B receptors. J. Neurochem. 60:380-383 (1993).
8. 1Dβ receptor subtype in human cortex. Eur. J. Pharmacol. 242:195-198 (1993).
9. 1B binding sites in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 347:569-582 (1993).
10. Hoyer, D., and D. N. Middlemiss. Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain. Trends Pharmacol. Sci. 10:131-132 (1989).
11. 1Dβ receptor subtype in human and bovine cerebral arteries. Mol. Pharmacol. 44:242-246 (1993).
12. 1-like receptors: six down and still counting. Trends Pharmacol. Sci. 14:228-231 (1993).
13. 1F receptor binding sites in the guinea pig brain: an autoradiographic study. Naunyn-Schmiedeberg's Arch. Pharmacol. 352:263-275 (1995).
14. Hoyer, D., D. E. Clarke, J. R. Fozard, P. R. Hartig, G. R. Martin, E. J. Mylecharane, P. R Saxena, and P. P. A. Humphrey. VII. International Union of Pharmacology Classification of Receptors for 5-Hydroxytryptamine (Serotonin). Pharmacol. Rev. 46:157-203 (1994).
15. 1B receptor. Science (Washington D. C.) 265:1875-1878 (1994).
16. 1B receptor agonist, blocks neurogenic plasma extravasation within rat but not guinea pig dura mater. Br. J. Pharmacol. 104:3-4 (1991).
17. 3H]5-carboxamidotryptamine binding sites in the guinea pig and rat brain. Eur. J. Pharmacol. 283:31-46 (1995).
18. Macor, J. E., D. H. Blank, R. J. Post, and K. Ryan. The synthesis of a conformationally restricted analog of the anti-migraine drug sumatriptan. Tetrahedron Lett. 33:8011-8014 (1992).
19. McCarthy, B. G., and S. J. Peroutka. Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR 43175). Headache. 29:420-422 (1989).
20. 7) positively linked to adenylate cyclase. J. Biol. Chem. 268:23422-23426 (1993).
21. Matsubara, T., M. A. Moskowitz, and Z. Huang. UK-14,304, R(-)-α-methyl-histamine, and SMS 201-995 block plasma protein leakage within dura mater by prejunctional mechanisms. Bur. J. Pharmacol. 224:145-150 (1992).
22. Moskowitz, M. A. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol. Sci. 13:307-311 (1992).
23. 1B receptor messenger RNA in neurons of the rat trigeminal ganglion. Eur. J. Pharmacol. 227:357-359.
24. 1Dα serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development. Proc. Natl. Acad. Sci. USA 91:3666-3669 (1994).
25. Bouchelet, I., Z. Cohen, B. Case, P. Séguéla, and E. Hamel. Expression of sumatriptan-sensitive serotonin receptors mRNA in human neuronal and vascular tissues. Soc. Neurosci. Abstr. 21:727.11 (1995).
26. 1B receptors. Eur. J. Pharmacol. 290:95-103 (1995).
27. 1B knockout mice. Soc. Neurosci. Abstr. 21:694.11 (1995).
28. 1B knockout mice: experiments in hippocampal, frontal cortex and midbrain raphé slices. Neuroreport 7:353-359 (1995).
29. 1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation. Br. J. Pharmacol. 116:2385-2390 (1995).